Vitro Biopharma Receives Approval for Presentation to the International ... MarketWatch (press release) There are over 200 ongoing clinical trials of MSCs to study potential treatment of diabetes, Parkinson's disease, organ transplant rejection, osteoarthritis, MS, spinal cord injury, stroke, myocardial infarction, cardiovascular disease, ... |
